give me a reality baesd case study based on sulphas poisning in short taken accidentally
Reading File
Finding Sources
Searching the Web
accidental sulpha sulfonamide poisoning case study clinical presentation treatment
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Here is a short, reality-based case study on accidental sulpha (sulfonamide) poisoning:
Case Study: Accidental Sulpha Drug Poisoning
Patient: 6-year-old boy, 18 kg, no known drug allergies
Background:
The child's mother was prescribed co-trimoxazole (trimethoprim-sulfamethoxazole, 480 mg tablets) for a urinary tract infection. She stored them in a pill organizer on the kitchen counter. The child mistook the tablets for candy and ingested approximately 6 tablets (about 2,880 mg of the combination) while unsupervised.
Presentation (within 2-4 hours):
- Nausea, vomiting, abdominal cramps
- Drowsiness and irritability
- Reduced urine output noted by evening
- Mother noticed pink-tinged urine (early hematuria)
- Brought to the emergency department
On Examination:
- Temp: 37.8°C (low-grade fever)
- Pale, slightly drowsy
- Mild tenderness over the flanks
- Urine dipstick: blood 2+, protein trace
Labs:
- CBC: mild fall in WBC (early bone marrow effect)
- Serum creatinine: slightly elevated (0.9 mg/dL vs baseline ~0.5)
- Urinalysis: crystalluria (needle-shaped sulfonamide crystals) on microscopy - a hallmark of sulpha toxicity
- Normal electrolytes initially; later, mild hyperkalemia noted
Pathophysiology (What Happened):
Sulfonamides have low solubility in acidic urine. In overdose, they precipitate in renal tubules as crystals (crystalluria), causing obstructive nephropathy and hematuria. The drugs also cause:
- Bone marrow suppression (blood dyscrasias)
- Hypersensitivity reactions (rash, urticaria, rarely Stevens-Johnson syndrome)
- Hemolysis in G6PD-deficient patients
- In high doses - CNS drowsiness and paresthesias
(Source: The Harriet Lane Handbook, 23rd ed.; Goodman & Gilman's Pharmacological Basis of Therapeutics)
Management:
| Step | Action |
|---|---|
| Immediate | Stop exposure; gastric lavage/activated charcoal if within 1 hour |
| Hydration | Aggressive IV fluid hydration to flush crystals from tubules and alkalinize urine |
| Urinary alkalinization | IV sodium bicarbonate - raises urine pH, increasing sulfonamide solubility |
| Monitoring | Serial renal function, CBC, urine output, and electrolytes every 6-8 hrs |
| Skin watch | Monitor for rash (maculopapular rash typically appears 7-12 days post-exposure) |
| Antihistamines | For early urticarial reaction if any |
| Escalation | Nephrology consult if creatinine continues to rise |
Outcome:
With 48 hours of IV fluids, urinary alkalinization, and supportive care, urine output improved, crystals cleared from the urine, and renal function normalized. The child was discharged on day 3 with no long-term sequelae.
Lesson: Child-proof storage of all medications is essential. Sulpha drugs in overdose primarily threaten the kidneys through crystal-induced obstruction. Early aggressive hydration and alkalinization are the cornerstones of treatment.
Key Toxicity Points (Sulpha/Sulfonamide Poisoning):
- Renal: Crystalluria, hematuria, obstructive nephropathy
- Hematologic: Blood dyscrasias, hemolytic anemia (especially G6PD deficiency), bone marrow depression
- Dermatologic: Maculopapular rash (7-12 days), urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis
- CNS: Drowsiness, paresthesias (at high doses)
- Electrolytes: Hyperkalemia (especially in HIV patients), hyponatremia
- Hepatic: Transaminase elevation, hepatic injury
(References: The Washington Manual of Medical Therapeutics; The Harriet Lane Handbook, 23rd ed.; Goodman & Gilman's)
This is a shared conversation. Sign in to Orris to start your own chat.